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In recent years, it has become apparent that the Wnt signaling pathway, known for its 
essential functions in embryonic development and tissue homeostasis, exerts immuno-
modulatory functions during inflammation and infection. Most functional studies indicate 
that Wnt5a exerts pro-inflammatory functions on its cellular targets, which include 
various types of immune and non-immune cells. Wnt5a expression has also been linked 
to the pathogenesis of chronic inflammatory diseases. Activation of beta-catenin-de-
pendent Wnt signaling, e.g., by Wnt3a, has however been shown to limit inflammation 
by interfering with the nuclear factor kappa-light chain-enhancer of activated B-cells 
(NF-kappaB) pathway. This review focuses on the regulation of Wnt5a, Wnt3a, and the 
recently identified Wnt6 and their functional role in bacterial infections with a primary 
focus on pulmonary tuberculosis, a leading infectious cause of morbidity and mortality 
worldwide.
Keywords: Mycobacterium tuberculosis, wnt proteins, inflammation, macrophages, toll-like receptors, 
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TUBeRCULOSiS (TB): OveRview AND PATHOGeNeSiS
With 1.5 million fatalities in 2014, TB ranks alongside with the human-immunodeficiency virus 
(HIV/AIDS) as the leading-cause of death from infectious disease worldwide (1). The causative 
agent of TB belongs to the genus Mycobacteria and to the Mycobacterium tuberculosis complex, 
which comprises of several closely related pathogenic sub-species (2). Mycobacterium tuberculosis 
(M. tuberculosis) is a non-motile, slow growing, gram-positive bacterium with a lipid-rich cell wall. 
The pathogen is adapted to an intracellular lifestyle, allowing it to survive and replicate within its 
main host cell, the macrophage (3, 4). TB primarily affects the lung (pulmonary TB) and is usually 
transmitted by inhalation of very small bacteria-containing droplets (aerosols).
Having entered the lung, M. tuberculosis is ingested by alveolar macrophages and elicits a localized 
inflammatory response, which, by production of a range of cytokines and chemokines, leads to early 
recruitment of mono- and polymorph nuclear cells from neighboring blood vessels to the infectious 
foci (5, 6). This leads to the formation of a cluster of immune cells termed granuloma, the hallmark 
of TB infection. Initial stages are mainly characterized by an amorphous mass of tissue resident- and 
monocyte-derived macrophages (7). Naïve T-cell differentiation is driven by antigen-presenting 
dendritic cells that have migrated to the local lung-draining lymph node (8). Subsequently, antigen-
specific T-cells enter the site of infection and the granuloma lesion stratifies. During progression of 
disease, some cells differentiate into multinucleated giant cells and foamy macrophages. Infected 
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macrophages in the core of the granuloma are enclosed by unin-
fected and foamy macrophages, which, in turn, are surrounded 
by varying fractions of T- and B-lymphocytes in the periphery 
(9–11). In “late” phase granulomas, a fibrous cuff may separate 
macrophages from lymphocytes, while the center of the granu-
loma necrotizes, generating the liquefied core termed “caseum.” 
A functional disintegration of the granuloma ultimately leads to 
the release of viable, extracellular mycobacteria into the airways. 
This facilitates transmission of disease by coughing and sneezing 
of the patient.
TB: LiGANDS, ReCePTORS, AND SiGNAL 
TRANSDUCTiON PATHwAYS
Cell wall components such as lipoproteins, lipoarabinomannans, 
and mycolic acids represent conserved mycobacterial structures, 
which are recognized by pattern recognition receptors (PRRs) of 
the immune system [recently extensively reviewed in Ref. (12)]. 
Among these, the family of Toll-like receptors (TLRs) significantly 
contributes to the initiation of the first line defense response 
against the invading pathogen. Engagement of TLRs initiates 
downstream signaling events, which are orchestrated by various 
adaptor proteins, including the myeloid differentiation primary 
response gene 88 (MyD88) (13, 14). TLR-MyD88-signaling leads 
to the translocation of nuclear factor kappa-light chain-enhancer 
of activated B-cells (NF-kappaB) into the nucleus, which induces 
the transcription of a variety of cytokines and chemokines, 
including interleukin (IL)-12 and tumor necrosis factor alpha 
(TNF-alpha). TNF-alpha is a pro-inflammatory cytokine mainly 
secreted by macrophages, which was shown to mediate early leu-
kocyte recruitment and granuloma formation in mice (15–18). 
TNF-alpha expression is critically linked to host protection, since 
latently M. tuberculosis-infected individuals (19) that received 
anti-TNF reagents to treat inflammatory diseases (e.g., rheu-
matoid arthritis) showed an enhanced TB reactivation risk (20). 
TLR-induced macrophage activation and the release of cytokines 
and chemokines contribute to the initiation of adaptive immunity 
(21). Antigen-specific T-helper cells type 1 (Th1), migrating to the 
site of infection, secrete interferon-gamma (IFN-gamma), which 
is critical for the host defense against M. tuberculosis (22, 23). It 
induces a profound transcriptional remodeling of macrophages 
(24), which sensitizes cells for a more rapid and heightened 
response to TLR-ligands (25). Synergistic action of IFN-gamma 
and TLR-ligands “fully” activates macrophages (also referred to 
as classical activation of macrophages) (25) and enables cells to 
exert tuberculostatic functions (26, 27). Although it has been 
shown that TLR2 and Myd88 are not essentially required for the 
induction of adaptive T cell responses, MyD88 - but not TLR2, 
TLR4, and TLR9 - is critical for triggering macrophage effector 
mechanisms central to anti-mycobacterial defense (28, 29).
wnt SiGNALiNG: OveRview
The Wingless/Integrase 1 (Wnt) signaling pathway, which is evo-
lutionary highly conserved in multicellular eukaryotic animals 
(metazoa), regulates basic cellular processes such as proliferation 
apoptosis, differentiation, polarization, and motility [reviewed 
in Ref. (30–32)]. Exerting fundamental functions on cells, Wnt 
signaling plays a crucial role during embryogenesis, but also 
throughout adult life by maintaining homeostasis in virtually 
every tissue and organ. Regarding the lung, as the organ primar-
ily affected during TB, Wnt signaling regulates various processes 
during organogenesis including branching morphogenesis and 
regional specialization of the epithelium and mesenchyme thereby 
shaping the architecture of the airways not only in mice but also 
in other animal species [reviewed in Ref. (33, 34)]. Moreover, 
dysregulation of Wnt signaling has been linked to lung diseases 
such as lung cancer, pulmonary fibrosis, or pulmonary arterial 
hypertension (33, 34).
With regard to the immune system, there is evidence that Wnt 
signaling is necessary for normal hematopoiesis (35). Moreover, 
the work of the last years shows that Wnt signaling affects immune 
cell function during inflammation and infection, demonstrating 
that this ancient and conserved signaling pathway also regulates 
processes beyond development and homeostasis. Recent work 
indicates that Wnt ligands and downstream signaling molecules 
shape inflammation and the host response to pathogens by 
modulating various immune cell functions, including cytokine 
production, immune cell migration, or differentiation [reviewed 
in Ref. (36–38)]. The heterogeneity and complexity of Wnt regu-
lated functions are reflected by the presence of numerous recep-
tors, which integrate the signals of various ligands, altogether 
determining cellular functions of target cells.
wnt SiGNALiNG: LiGANDS, ReCePTORS, 
AND SiGNAL TRANSDUCTiON PATHwAYS
The human and the mouse genome harbor 19 independent Wnt 
genes (39), which show distinct expression patterns depending 
on the cellular context. Wnt genes encode for Wnt ligands which 
are cysteine-rich, glycosylated, lipid-modified, and secreted 
proteins with a molecular weight of approximately 40 kDa (40). 
Wnts can act as short-range mediators as they stick to secreting 
cells or the extracellular matrix (41). To exert their action across 
a distance in tissues (e.g., as morphogen), it was proposed that 
Wnts are associated with lipoprotein particles (42). It has also 
been demonstrated that they are released in small extracel-
lular micelles from endocytic origin, the exosomes (43). This 
extracellular vesicular transport enables Wnts to bypass long 
distances and, as they are exposed on the surface of the exosome, 
to efficiently bind to their receptors and induce signaling in their 
target cells. Wnt proteins mainly engage Frizzled (Fzd) family 
members to transduce signals into target cells. In addition, 
several coreceptors such as lipoprotein-receptor-related protein 
(LRP) participate in Wnt signaling (44). The 10 mammalian 
Fzd proteins are seven-transmembrane receptors, belonging to 
the family of G-protein-coupled receptors (45–47). Fzd recep-
tors comprise of three different domains, the large N-terminal 
cysteine-rich extracellular region (CRD), the central core with 
seven hydrophobic membrane spanning alpha helices, and the 
cytoplasmatic region. Recently, the successful crystallization of 
Xenopus Wnt8 complexed to the CRD of Fzd8 gave first insights 
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into the structural basis of ligand-receptor binding (48). For 
signal transduction inside the target cell, the cytoplasmatic 
region of Fzd receptors mediates binding of adaptor proteins 
such as dishevelled (Dvl) or heterotrimeric G-proteins (49, 50). 
To date, at least three distinct signaling cascades are known to 
be induced by ligand-receptor binding: the Wnt/beta-catenin 
pathway, the beta-catenin independent Wnt/Ca2+ pathway, and 
Wnt/Planar cell polarity pathway [reviewed in Ref. (51) and 
described below].
wnt SiGNALiNG PROMOTiNG 
iNFLAMMATiON - wnt5a
Our group was the first who linked the activity of Wnt signaling 
to infectious disease mechanisms operative in pulmonary TB. 
We showed that Wnt5a and its putative receptor Frizzled5 (Fzd5) 
are present in lung biopsies of TB-patients, that mycobacteria 
induce Wnt5a in macrophages in a TLR-NF-kappaB dependent 
manner, and that Wnt5a exerts a distinct immunomodulatory 
function on immune cells (52). This observation was well in line 
with earlier findings by Sen et al., who had observed an enhanced 
presence of Wnt5a in inflamed synovial tissue of rheumatoid 
arthritis patients and had assigned a functional role for Wnt5a 
in the pathogenesis of this chronic inflammatory disease (53). 
During the last 10  years, an increased Wnt5a expression was 
observed in a variety of inflammatory disease settings such as 
skin lesions of patients with psoriasis vulgaris (54) or cutaneous 
lichen planus (55), obesity-induced adipose tissue inflammation 
(56, 57), atherosclerotic lesions (58), and in the sera of patients 
with septic shock (59). With regard to infections, Wnt5a induc-
tion has been described in response to a variety of pathogens 
(60, 61). While mostly human macrophages were studied, Bansal 
et al. could show that Wnt5 is expressed in murine macrophages 
after infection with Mycobacterium bovis BCG - but not with 
Mycobacterium smegmatis (62). Notably, the authors show that 
the induction of Wnt5a is also dependent on the presence of TLRs. 
Also engagement of the C-type lectin dectin-1 was shown to drive 
Wnt5a formation in macrophages (63). In addition to human and 
murine cells, an increased expression of Wnt5a was also observed 
in Mycobacterium marinum-infected adult zebrafish (64), dem-
onstrating that induction of Wnt5a upon infection is a conserved 
mechanism.
Beside the abovementioned TLRs and dectin-1, a whole 
variety of PRRs contribute to host cell activation by pathogenic 
mycobacteria and were shown to be involved in mounting an 
anti-mycobacterial response. This includes the macrophage 
inducible C-type lectin (MINCLE), macrophage scavenger 
receptor A (SRA), macrophage receptor with collagenous 
structure (MARCO), and the intracellularly located nucleotide-
binding oligomerization domain-containing protein 2 (NOD2), 
NLR family, pyrin domain-containing 3 (NLRP3), as well as 
the dsDNA sensor cyclic GMP-AMP synthase (12). It is cur-
rently not known whether ligand binding to these receptors 
and the resulting downstream signaling pathways contribute 
to the M. tuberculosis-induced expression of Wnt proteins in 
macrophages.
The work of many independent laboratories has shown that 
Wnt5a mainly exerts pro-inflammatory functions on its cellular 
targets, which include non-immune cells (65, 66) as well as vari-
ous types of immune cells (52, 56, 59, 67–69). In macrophages, 
Wnt5a has been shown to activate the Wnt/Ca2+ pathway (59), 
which leads to an increase in cytoplasmic Ca2+ levels thereby 
activating Ca2+-dependent factors such as Proteinkinase C, Ca2+/
calmodulin-dependent kinase II (CaMKII), and Calcineurin. 
Independent laboratories have shown that there is an intense 
crosstalk between the Wnt5a-induced signaling cascade and 
the NF-kappaB as well as certain mitogen-activated protein 
kinase pathways (56, 70, 71). Under homeostatic conditions, 
the Wnt5a–Fzd5–NF-kappaB (p65) signaling axis was shown 
to sustain macrophage immune functions (70). It was demon-
strated that Wnt5a stimulates phagocytosis, but does not affect 
bacterial killing by macrophages (68). Wnt5a induces endothelial 
inflammation (65) and contributes to CXC chemokine 12-ligand 
mediated T-cell migration (67). In the context of mycobacterial 
infections, Wnt5a exerts important functions by bridging innate 
and adaptive immunity: the antigen response of peripheral blood 
mononuclear cells (PBMCs) of purified protein derivative of M. 
tuberculosis (PPD) reactive healthy donors is altered by blocking 
Wnt5a or its putative receptor Fzd5 (52). Both, the production 
of the cytokine IL-12, critical for dendritic cell migration and T 
cell priming during TB infection (72), and T cell derived IFN-
gamma, critical for “full” activation macrophages, are significantly 
reduced in PBMCs incubated either with a neutralizing antibody 
or an antiserum against Wnt5a or Fzd5, respectively (52). These 
findings suggest that Wnt5a plays an important regulatory role 
during the host response to M. tuberculosis infection by activat-
ing innate immune cells, which in turn directly affects adaptive 
immune cell function. However, Wnt5a expression and its pro-
inflammatory activity have also been linked to the pathogenesis 
of multiple chronic inflammatory diseases, including rheumatoid 
arthritis (66), psoriasis (73), colitis (69), atherosclerosis (74–76), 
and obesity (56, 57). With regard to TB, however, it remains 
elusive whether excessive Wnt5a formation may contribute to the 
M. tuberculosis-induced immunopathology.
wnt SiGNALiNG LiMiTiNG 
iNFLAMMATiON - wnt/BeTA-CATeNiN 
SiGNALiNG
Wnt/beta-catenin signaling is characterized by Wnt ligand 
binding to Fzd and LRP coreceptors, leading to the recruitment 
of heterotrimeric G-proteins and the adaptor protein Dvl to 
the membrane (77). Subsequently, the so-called “destruction 
complex,” which continuously tags beta-catenin for proteasomal 
degradation by the activity of kinases such as glycogen-synthase 
kinase-beta (GSK3beta), dissociates (78). The accumulation 
of beta-catenin in the cytoplasm and its translocation into the 
nucleus leads to activation of gene expression mediated by the 
transcription factors T-cell factor and lymphoid enhancer-
binding factor (TCF/LEF).
In M. tuberculosis aerosol infection experiments, we system-
atically screened the mRNA expression of all 19 Wnt genes (79) 
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and Fzd receptors (80) in lungs of infected mice. We were able 
to detect all 19 Wnt genes at all time points analyzed but found 
a very prominent expression pattern. The mRNA expression of 
Wnt2, 2a, 3a, 4, 5a, 7a, 8a, and 10b was significantly reduced dur-
ing infection whereas Wnts 5b, 8b, 9a, 9b, 11, and Wnt16 were 
not regulated. These results complement data from an earlier 
study, which demonstrated that also the mRNA expression of the 
majority of Fzd receptors is downregulated after M. tuberculosis 
infection (80). The bacterial burden in the lung is characterized 
by a rapid increase of bacterial numbers between day 1 and day 
21 postinfection (p.i.) followed by a plateau of M. tuberculosis 
replication until day 42. During the first 3  weeks, a massive 
inflammatory response in the lung in response to infection is 
established in order to limit the growth of the pathogen. This is 
characterized by the induction of a robust T cell response and the 
formation and release of pro- and anti-inflammatory mediators. 
Thus, when analyzing gene expression in the lung, we observe 
an inverse correlation of Wnt expression and the formation of 
pro-inflammatory factors. Although the individual signaling 
induced by a given Wnt protein needs to be studied on the cellular 
level, most of these downregulated Wnt factors were previously 
associated with Wnt/beta-catenin signaling. This is well reflected 
by a reduced expression of the known Wnt/beta-catenin target 
gene and feedback regulator Axin2 (81), which was reduced by 
approximately 50% at days 21 and 42 p.i. (80). In line with our 
data, in the lung of Streptococcus pneumoniae-infected mice, a 
reduced Wnt activity has been observed by kinase activity profil-
ing (82).
Notably, M. tuberculosis-infected mouse lungs in  vivo and 
-infected macrophages in  vitro showed significantly enhanced 
expression levels of the receptor Frizzled1 (Fzd1) (80). Moreover, 
Fzd1 surface expression was increased by stimulation of mac-
rophages with the key cytokine IFN-gamma. Initially, we were 
puzzled by this observation, because Fzd1 has been clearly linked 
to Wnt/beta-catenin signaling, while IFNgamma is known to boost 
pro-inflammatory responses of macrophages to TLR-ligands 
(25). In a variety of in vivo studies, it was shown that mimick-
ing activation of Wnt/beta-catenin signaling by administration 
of a GSK3beta inhibitor potently suppresses pro-inflammatory 
responses and thereby protects animals from pathophysiological 
conditions (83–86). Due to the fact that epithelial cells in the 
lung did heavily stain for Wnt3a (80), we hypothesized that 
upregulation of Fzd1 renders the macrophages more sensitive 
to Wnt/beta-catenin signaling. And indeed we observed that 
macrophages reacted to Wnt3a stimulation or GSK3beta inhibi-
tion with beta-catenin stabilization and prominently enhanced 
Axin2 transcript levels, which was accompanied by a significant 
reduction of M. tuberculosis-induced TNF-alpha formation. This 
demonstrated that the Wnt3a-induced signal interferes with the 
M. tuberculosis-induced TLR2-dependent macrophage activa-
tion in vitro. To our knowledge, this was the first observation of 
a counter-regulation of TLR/NF-kappaB/IFNgamma and Wnt/
beta-catenin signaling in infected macrophages. Interestingly, 
this phenotype of a Wnt/beta-catenin negative feedback loop, 
which represses TLR-triggered inflammatory responses, was also 
observed in alveolar epithelial cells (87). Along the same line, 
another beta-catenin-dependent Wnt, Wnt2 has been shown to 
inhibit enteric bacterial-induced inflammation also in intestinal 
epithelial cells (88).
Depending on the cellular context, other Wnt-independent 
pathways may also lead to inhibition of GSK3beta, as e.g., shown 
for the integrin-linked kinase, an enzyme regulated by integrin 
signaling, which was shown to stabilize beta-catenin and to 
activate its target genes (89). It also needs to be considered that 
infections with pathogenic microorganisms (including M. tuber-
culosis) are often associated with severe tissue damage. This leads 
to the release of various intracellular factors such as adenosin 
triphosphate (ATP), heat shock proteins, mitochondrial compo-
nents and several alarmins, a group of proteins which include 
high-mobility group box 1 protein, IL-1α, IL-33, and the Ca2+-
binding S100 proteins [reviewed in Ref. (90)]. Recent studies 
suggest that some of these factors indeed interfere with GSK3beta 
activity and affect beta-catenin stabilization and the expression of 
related target genes. Guo et al. observed that activation of P2X7R 
by BzATP caused the death of alveolar epithelial cells type I by 
suppressing Wnt/beta-catenin signaling through stimulating 
GSK3beta (91). In contrast, S100 A8/A9 proteins have been 
shown to induce beta-catenin signaling in macrophages (92).
OPPOSiNG ROLeS OF wnt5a AND wnt/
BeTA-CATeNiN SiGNALiNG iN 
iNFLAMMATiON
In a model of endotoxic shock, lung homogenates from rats 
that received lipopolysaccharide (LPS) exhibited a decrease 
in levels of Wnt3a, Fzd1, phosphorylated GSK3β at Ser9, total 
β-catenin, and nuclear beta-catenin, demonstrating that major 
constituents of the Wnt3a signaling machinery in the lung 
were downregulated. In contrast, Wnt5a, Fzd5, total CaMKII, 
and phosphorylated CaMKII were upregulated, indicating that 
Wnt5a dependent, pro-inflammatory Ca2+/calmodulin signaling 
is strongly activated in endotoxemic rats (93). These findings are 
corroborated by Villar et  al. who observed that lungs of septic 
animals and humans are characterized by acute lung inflamma-
tion, collagen deposition, and marked increase of Wnt5a (94). 
These data show that in certain acute inflammatory situations 
pro-inflammatory Wnts, such as Wnt5a are induced, whereas 
Wnt/beta-catenin associated signals are downregulated. As 
mentioned above mimicking activation of Wnt/beta-catenin 
signaling by administration of a GSK3beta inhibitor protects 
animals from pathophysiological conditions. This was shown 
in mice receiving the TLR4 agonist LPS which were protected 
from endotoxin shock (84, 86), and in Francisella-infected mice, 
which were protected against tularemia (95). On a cellular level 
there is very likely a tightly controlled signal integration of both 
pathways. Not only in primary macrophages (37, 80), but also in 
dendritic cells beta-catenin has been shown to regulate the balance 
between inflammatory and regulatory responses. Beta-catenin in 
intestinal dendritic cells was required for the expression of anti-
inflammatory mediators and the stimulation of regulatory T cell 
induction, while suppressing inflammatory effector T cells (96). 
Furthermore, ablation of beta-catenin expression in dendritic 
cells enhanced inflammatory responses and disease in a mouse 
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model of inflammatory bowel disease. Thus, beta-catenin signal-
ing programs dendritic cells to a tolerogenic state, regulating, and 
limiting the inflammatory response (96). During the process of 
infection, this balance is very likely to change. Once the acute 
phase of an infection has passed, it is likely that Wnt/beta-catenin 
signals regain more and more activity over time as it is known 
that its downstream effects are also associated with termination 
of infection or inflammation and the reestablishment of homeo-
stasis. The latter has been shown in bacteria-induced injury of the 
urogenital tract (97) during which activation of Wnt/beta-catenin 
signaling promotes the regenerative response to bacterial injury. 
This is well in line with the observation that Wnt signaling induces 
epithelial differentiation during cutaneous wound healing (98).
wnt6 AND iTS ROLe DURiNG DiSeASe
In the murine lung, only 3 out of 19 Wnt ligands were upregulated 
after M. tuberculosis infection (79). Whereas Wnt1 and Wnt10a 
were expressed to a significantly higher extent only at day 42 p.i., 
mRNA expression of Wnt6 was increased significantly at days 21 
and 42 p.i. (79). Performing immunohistochemical analyses of 
lung tissue sections, we found Wnt6 in the M. tuberculosis-infected 
lung at both time points analyzed, but not in the uninfected lung. 
To our knowledge, this was the first description of Wnt6 expres-
sion in the lung. Notably, Wnt6 expression was exclusively found 
in M.  tuberculosis-infected cells within granulomatous lesions, 
which could be stained for CD68, a well known marker for 
myeloid cells such as monocytes and macrophages. Subsequent 
in vitro studies in primary cells showed that Wnt6 is macrophage-
derived immunomodulatory factor, which impairs expression 
and release of the key cytokine TNF-alpha during mycobacterial 
infections (79). Remarkably, Wnt6-conditioned medium (Wnt6 
CM) added to primary murine macrophages induced c-Myc 
expression, while c-Myc expression was significantly reduced 
in Wnt6-deficient cells when compared to respective control 
cells. The transcription factor c-Myc is a global regulator of 
chromatin which regulates diverse cellular processes including 
cell cycle (99). Indeed, Wnt6 CM also enhanced Ki-67 expression 
levels and 3[H]-Thymidin incorporation into cells, indicating that 
exogenous Wnt6 exerts proliferative effects on primary murine 
macrophages. However, exogenous Wnt6 did not enhance 
Axin2 mRNA levels or induce beta-catenin accumulation. These 
findings were surprising because (i) c-Myc is described as a 
well-known Wnt/beta-catenin-dependent target gene (100) and 
(ii) many reports describe that Wnt6-induced signaling is beta-
catenin dependent (101, 102). Recent insights into the structural 
basis of ligand-receptor interaction (48), showing conservation of 
interacting binding structures, suggest that the induced signaling 
and function of a certain Wnt ligand might not be predicted by 
its structure per se. It is known that Wnt5a can initiate discrete 
signaling pathways through the activation of distinct receptors 
(103). Moreover, when studying binding affinities of purified Wnt 
ligands to different Fzd CRDs, Wnt3a, -4, and -5a are functional 
binding partners for Fzd2, 4, and 5 with appreciable affinity 
(104). Only Wnt3a has the same effect on downstream signaling 
with each of the three receptors (104, 105), while it is described 
that the Wnt ligands, Wnt4 and Wnt5a, are also able to induce 
beta-catenin-dependent signaling in fusion with specific Fzds 
and coreceptors (105). These findings indicate that, although 
Wnt ligands may have a putative bias for individual signaling 
pathways (104), downstream consequences depend on the pres-
ence of receptors, coreceptors, competing ligands, and signaling 
components in the target cell and a given tissue. The receptor and 
coreceptor context in which Wnt6 engages a particular signaling 
pathway in macrophages is, however, not known to date.
So far, Wnt6 was described in the context of early embryo-
genesis (106, 107), during mouse embryonic gut (108), stomach 
(109), kidney (110), and heart (111) organogenesis as well as in 
tooth morphogenesis (112). Dysregulation of Wnt6 has been 
shown to be related to carcinogenesis: single nucleotide poly-
morphisms (SNPs) in the Wnt6 gene could be associated with 
enhanced risk for developing colorectal adenomas (113). Wnt6 
was also described to contribute to chemoresistance of gastric 
cancer cells (114). Both findings are in line with the observed 
proliferative effect of Wnt6 on macrophages.
The fact that Wnt6 is also induced by conserved microbial 
structures suggests that it may play a role not only during myco-
bacterial infections but also in the context of other infectious 
diseases. Indeed, Liu et  al. reported that Salmonella infection 
induces Wnt6 expression in intestinal epithelial cells (115). In 
a non-infectious context, Choy et al. showed that Wnt6 expres-
sion positively correlates with the Th2 signature observed in 
mild-to-moderate asthmatics (116). Collectively, the currently 
available data demonstrate that Wnt6 is expressed during M. 
tuberculosis infection, but may also be expressed in the context of 
other inflammatory and infectious disease settings. With regard 
to function, our study identifies Wnt6 as a macrophage-derived 
anti-inflammatory and pro-proliferative factor, which is likely to 
influence immune cell function during TB infection (79).
HOw MUCH wnt iS iN THe  
M. TUBERCULOSIS GRANULOMA?
The granuloma is the key pathologic feature of TB. Granulomas 
serve as an immunological microenvironment, which enable the 
host to contain microbes and control disease and, at the same 
time, act as a niche for the pathogen in which the bacteria can 
persist or even grow (117, 118). As a highly dynamic structure, 
the granuloma changes appearance during the course of disease. 
In addition, there is substantial granuloma heterogeneity, as 
granulomas with varying cellular composition exist within the 
same animal or patient (119, 120). It is widely accepted that the 
activation of robust Th1-dominated adaptive immune responses 
characterized by (i) efficient migration of antigen-specific T-cells 
into the lung, (ii) a profound IFNgamma release, and (iii) high 
numbers of classical activated macrophages at the site of infection 
are essential to efficiently restrict bacterial growth (22, 23, 121, 
122). However, uncontrolled pro-inflammatory Th1 responses 
causing excessive tissue damage, which affects the functional 
integrity of the granuloma, may be detrimental for the host (123). 
Available data demonstrate that Wnt signaling is regulated during 
lung inflammation and suggest that the activity of beta-catenin-











• expressed in a subset of lipid body-positive MФ
• dampens Mtb-induced TNF-α release 
induces c Myc expression in
Fzd1 
• surface expression enhanced by IFNγ
Wnt3a
Wnt5a
• contributes to TB antigen response 
of human PBMC
induces IL 12 formation • -
a β-catenin-independent manner
• exerts proliferative effects on MФ
• induces β-catenin stabilization in MФ
• dampens Mtb-induced TNF-α formation
• -
• promotes IFNγ release
FiGURe 1 | The role of wnt signaling in M. tuberculosis infection.
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inflammation and infection. Studies in non-human primates 
showing that even during active disease some lesions are sterile 
(119, 120), and recent results from patients showing that pro- and 
anti-inflammatory signals are physically segregated within each 
granuloma (124), suggest that local mechanisms rather than 
systemic inflammatory responses dictate the functional integrity 
of the granuloma. Moreover, it seems likely that other factors than 
cytokines present within the segregated microenvironments of the 
granuloma contribute to its “homeostasis.” Wnts act on immune 
cells in different ways as described above. This does not only 
include immunomodulatory functions as shown for Wnt5a and 
Wnt3a, but affects immune cell differentiation and proliferation 
as shown for Wnt6 (summarized in Figure 1). Although in vivo 
studies are missing, current data on Wnt6 imply that this factor, 
acting as an anti-inflammatory and pro-proliferative mediator 
in vitro, attenuates tissue inflammation and drives macrophage 
differentiation during TB infection. In addition Wnt6 is expressed 
a subset of lipid body-positive macrophages in M. tuberculosis-
infected. (79). Foamy macrophages are considered as key cells, 
which constitute a nutrient-rich reservoir for M. tuberculosis 
persistence and contribute to tissue pathology (125, 126). There 
is increasing evidence that Wnt signaling is of critical impor-
tance for cellular lipid metabolism (127). Mani et al. identified 
Wnt signaling as a regulator of plasma lipid composition and as 
target for treatment of hyperlipidemia (128). Whether there is 
a link between Wnt6 and the formation of foamy macrophages 
in M. tuberculosis infection remains to be shown. The impact 
of Wnts may even target other important pathways in the host 
mycobacteria interaction. Activation by Wnt3a augments 
M. bovis BCG-induced apoptosis in RAW264.7 macrophages 
(129), indicating a modulation of cellular cell death pathways by 
Wnt/beta-catenin signaling in macrophages. In addition, the 
characterization of the microRNA profile circulating of patients 
with active pulmonary TB has led to the identification of increased 
levels of miR-29a (11.9- and 5.2-fold) in the TB serum and in 
the TB sputum, when compared to the expression of the controls 
(130). This is an important observation since MiR-29a directly 
targets negative regulators of Wnt signaling (131). Taken together, 
although Wnt expression is detected within tuberculous lesions, 
it is currently not clear how much of a given Wnt is “seen” by a 
macrophage and other immune cells in the granuloma and how 
this impacts the outcome of disease.
PATHOGeNS eXPLOiTiNG  
wnt SiGNALiNG
Whereas Wnt/beta-catenin signaling is host protective in many 
of the above mentioned infection models, it has also been shown 
that certain pathogens harness Wnt signaling components to 
promote infection. In a very recent study, Ehrlichia chaffeensis, 
an obligate intracellular bacterium responsible for the emerging 
life-threatening zoonosis human monocytotropic ehrlichiosis 
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exploits beta-catenin-dependent and beta-catenin-independent 
host Wnt signaling pathways to stimulate phagocytosis and 
promote intracellular survival (132). Ehrlichial tandem repeat 
proteins were identified to be responsible for these effects. siRNA 
knockdown of several Wnt signaling pathway components or 
targets influences significantly reduced ehrlichial infection in 
human THP1 macrophages. A second example is Chlamydia 
trachomatis (Ctr) representing another gram-negative bacterium 
which exploits Wnt/beta-catenin signaling during infection. 
These bacteria disturb epithelial tissue homeostasis in fallopian 
tubes. The authors demonstrate that acute Ctr infection activates 
the paracrine Wnt signaling pathway, leading to profound disrup-
tion of epithelial cell structure and function, which facilitates the 
dissemination of damage beyond that of infected cells (133).
Also viruses have been shown to directly interfere with the 
Wnt signaling cascade. The activation of Wnt signaling has been 
demonstrated for the human polyoma virus JC (134), Epstein–
Barr virus (135), and Kaposi’s sarcoma-associated herpesvirus 
(136), being just a few examples of viruses which are known to 
lead to tumor development, an issue very recently reviewed (137). 
With regard to viral infections of the airways, adenoviruses are 
known to strongly interfere with the Wnt signaling machinery 
as several factors are heavily regulated during infection (138). 
In a very recent study, the 1918 influenza virus PB2 protein was 
shown to be a virulence factor interfering with inflammatory and 
Wnt-mediated signaling in mice. Both, beta-catenin-dependent 
and -independent Wnt signaling pathways were repressed and 
associated with impaired lung regeneration and repair (139). 
Taken together, this illustrates that depending on the infection 
mechanism and the infected host cell, pathogens may exploit the 
Wnt signaling machinery in a very specific manner.
wnts AND THe SUSCePTiBiLiTY TO 
iNFeCTiOUS DiSeASe
With regard to infectious diseases, SNPs in the Wnt signaling 
cascade have been mainly associated with the risk of cancer devel-
opment upon infection. It was shown that beta-catenin mutations 
are frequent in human hepatocellular carcinomas associated with 
hepatitis C virus (HCV) infection (140). In addition, WNT signal-
ing pathway gene polymorphisms are related to the risk of hepatic 
fibrosis and inflammation in HCV-infected patients (141). In 
Helicobacter pylori infection, SNPs of MMP-9 -1562/TIMP-1 372 
have been associated with an enhanced risk of gastric intestinal 
metaplasia (142). With regard to TB there are indications that 
certain SNPs are associated - not just with the consequences of the 
disease as described above but with disease susceptibility (143). 
Based on studies in two cohorts, the authors identified three SNPs 
in the CTNNB1 gene resulting in lower beta-catenin mRNA and 
protein levels, which were associated with a decreased risk of 
developing TB. By contrast, two SNPs associated with SFRP1, 
which were associated with higher C-reactive protein levels 
that were significantly associated with TB risk in a Chinese Han 
population, but not in a Tibetan group. These data are the first 
that suggest that Wnt pathway polymorphisms may influence TB 
susceptibility and host immune response. It will be interesting 
to see whether these observations will be seen in other, larger 
cohorts of different ethnicity, or whether this is a characteristic 
feature of these specific ethnic groups studied. To date, this recent 
study is to our knowledge the only one which directly links SNPs 
in Wnt signaling related genes to the susceptibility towards an 
infectious disease.
CONCLUDiNG ReMARKS
Pulmonary TB is one of the most complex infectious diseases 
known, characterized by severe chronic inflammation being 
important for bacterial growth restriction but also being respon-
sible for severe immunopathology. In the last 10 years, it has 
become clear that the immune function during M. tuberculosis 
infection is regulated by members of the Wnt signaling cascade. 
And still new factors and related functions are being identified. A 
simplified view on the systemic expression and functional role of 
each of the 19 individual Wnts in M. tuberculosis infection is cur-
rently not possible, since to our understanding local determinants 
define either the induction or repression of a given Wnt signaling 
factor and its related functions. The detailed characterization 
of the underlying signaling pathways and the identification of 
molecular interactions will lead to better understanding of the 
disease mechanisms and may even lead to the identification of 
new target structures in order to develop a shorter and more 
efficient therapy of pulmonary TB.
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